Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MGNX

MacroGenics (MGNX)

MacroGenics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGNX
DateTimeSourceHeadlineSymbolCompany
06/11/20247:45AMGlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferenceNASDAQ:MGNXMacroGenics Inc
06/04/20244:53PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGNXMacroGenics Inc
05/24/20245:08PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:MGNXMacroGenics Inc
05/23/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20245:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/23/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGNXMacroGenics Inc
05/23/20244:22PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGNXMacroGenics Inc
05/22/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/22/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGNXMacroGenics Inc
05/21/20244:12PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGNXMacroGenics Inc
05/13/20247:30AMGlobeNewswire Inc.MacroGenics to Participate in Upcoming Investor ConferencesNASDAQ:MGNXMacroGenics Inc
05/09/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGNXMacroGenics Inc
05/09/20244:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGNXMacroGenics Inc
05/09/20244:01PMGlobeNewswire Inc.MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study DataNASDAQ:MGNXMacroGenics Inc
05/03/20247:30AMGlobeNewswire Inc.MacroGenics Announces Date of First Quarter 2024 Financial Results Conference CallNASDAQ:MGNXMacroGenics Inc
04/03/20244:30PMGlobeNewswire Inc.MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future DisclosuresNASDAQ:MGNXMacroGenics Inc
 Showing the most relevant articles for your search:NASDAQ:MGNX